SCHEMBL4149136

SCHEMBL4149136

Fc1ccc(Nc2c[nH]nn2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.49
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
MAPT P10636 4/20 0.43
ALOX12 P18054 2/20 0.43
LMNA P02545 2/20 0.43
MAPK1 P28482 1/20 0.43
BPTF Q12830 1/20 0.42
POLB P06746 1/20 0.41
ALDH1A1 P00352 4/20 0.41
KCNH2 Q12809 1/20 0.40
SCN5A Q14524 1/20 0.40
SCN9A Q15858 1/20 0.40
BRAF P15056 1/20 0.38
USP2 O75604 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15831504 0.82 MAPT (0.43) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL828555 0.80 MEN1 (0.48) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL23457519 0.78 ABL1 (0.49) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL23457510 0.77 MAPT (0.47) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL15831508 0.76 RAPGEF4 (0.45) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL15831529 0.74 HTT (0.42) MAPTPOLBALDH1A1HTT
SCHEMBL13844997 0.71 MAPK10 (0.46) MAPK10MEN1KMT2ARAB9ANPC1
SCHEMBL23457500 0.70 MEN1 (0.37) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL23457623 0.69 SCN9A (0.38) RAB9ANPC1MAPTKCNH2SCN5A
SCHEMBL395770 0.68 ALDH1A1 (0.50) MAPK10MEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185586-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2023-05-31 EP disclosed
US-20090186918-A1 Triazole Compounds as Lipoxygenase Inhibitors BIOLIPOX AB (SE) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186918-A1 Triazole Compounds as Lipoxygenase Inhibitors ALOX15, ALOX15B, ALOX12 MAPK10 2235/4885MEN1 4656/4885KMT2A 3024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.